Unknown

Dataset Information

17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.


ABSTRACT:

Objective

17β-hydroxysteroid dehydrogenase isoform 12 (HSD17B12) overexpression is associated with poor clinical outcome in invasive ductal carcinoma of the breast. Here, we evaluated HSD17B12 overexpression and its activity in ovarian carcinoma (OvCa) to determine its role in the growth and progression of this tumor.

Methods

Immunohistochemical analysis of HSD17B12 expression was performed in 100 tissue samples of untreated OvCa and was correlated with clinicopathologic characteristics and patient outcome. In A2780 OvCa cell line expressing HSD17B12, siRNA knockdown of the enzyme was performed, and its effects on tumor cell growth and Annexin V binding were determined.

Results

HSD17B12 expression was detected in all tumor samples, but the staining intensity was varia

SUBMITTER: Szajnik M 

PROVIDER: S-EPMC3607433 | biostudies-literature | 2012 Dec

REPOSITORIES: biostudies-literature